AKT1 and renal cell carcinoma: Regarding other downstream effectors of adiponectin in RCC cells, Chou et al. revealed that adiponectin activates several signaling pathways, including the STAT3, S6, ERK1/2, and AKT pathways, in a dose-dependent manner in 786-O cells [12].